Clinical Trial Update: Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating post-transplant cyclophosphamide in patients aged 65 and older undergoing haploidentical transplantation for hematologic mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Ronald Paquette | Conditions: Hematologic Malignancies | Phase 1 | Status: RECRUITING